Cardiac Arrhythmias: New Therapeutic Drugs and Devices

Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984

Nonfiction, Health & Well Being, Medical, Specialties, Pharmacy, Internal Medicine, Cardiology
Cover of the book Cardiac Arrhythmias: New Therapeutic Drugs and Devices by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461325956
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461325956
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability of anyone model to define the probability of antiarrhythmic efficacy in man. It has therefore become standard practice to utilize a batter of animal models for the evaluation of new antiarrhythmic agents. Each model has its own advantages and disadvantages and it is necessary to understand each model fully in oder to evaluate experimental findings and apply them to clinical settings. We believe that the availability of the chronic myocardial infarction ventricular tachyarrhythmia model provides 1) an excellent opportunity to more precisely understand arrhythmia mechanisms, 2) to develop new techniques such as signal averaging for evaluating late low level potentials identifying hearts at high risk of sudden death 3) to identify new antifibrillatory drugs versus drugs that are effective primarily against PVC's and ventricular tachycardia 4) to identify new surgical techniques to eliminate VT/VF, and 5) to evaluate new pacing modalities including implantable cardioverters. Although all animal models are wrong, many are very useful in furthering our knowledge directed at decreasing the distressingly high mortality from heart disease. NORMAL HtART TACHYCMDIA HtART , .. '" \ I I I I I I I I I .

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability of anyone model to define the probability of antiarrhythmic efficacy in man. It has therefore become standard practice to utilize a batter of animal models for the evaluation of new antiarrhythmic agents. Each model has its own advantages and disadvantages and it is necessary to understand each model fully in oder to evaluate experimental findings and apply them to clinical settings. We believe that the availability of the chronic myocardial infarction ventricular tachyarrhythmia model provides 1) an excellent opportunity to more precisely understand arrhythmia mechanisms, 2) to develop new techniques such as signal averaging for evaluating late low level potentials identifying hearts at high risk of sudden death 3) to identify new antifibrillatory drugs versus drugs that are effective primarily against PVC's and ventricular tachycardia 4) to identify new surgical techniques to eliminate VT/VF, and 5) to evaluate new pacing modalities including implantable cardioverters. Although all animal models are wrong, many are very useful in furthering our knowledge directed at decreasing the distressingly high mortality from heart disease. NORMAL HtART TACHYCMDIA HtART , .. '" \ I I I I I I I I I .

More books from Springer US

Cover of the book Cattle Plague by
Cover of the book Causation and Disease by
Cover of the book Vaccine Design by
Cover of the book Cross-Media Service Delivery by
Cover of the book Polyphenylene Oxide and Modified Polyphenylene Oxide Membranes by
Cover of the book Routing and Quality-of-Service in Broadband LEO Satellite Networks by
Cover of the book The Physician Scientist's Career Guide by
Cover of the book Victimization in Schools by
Cover of the book Design of Interconnection Networks for Programmable Logic by
Cover of the book Alzheimer’s and Parkinson’s Diseases by
Cover of the book Theoretical Perspectives in Environment-Behavior Research by
Cover of the book Total Materials Management by
Cover of the book Studies in Consumer Demand — Econometric Methods Applied to Market Data by
Cover of the book Synchronized Phasor Measurements and Their Applications by
Cover of the book Deinstitutionalization and Community Living by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy